Ovarian cancer enzyme
Ovarian cancer
Cancer of the ovaries (ovarian carcinoma) accounts for a third of all malignant neoplasms of the female genitals and half of all deaths from cancer of these organs. The incidence rates rise continuously up to the age of 85, the mean age of illness is 68 years. Histologically, the malignant tumors of the ovaries are predominantly moderately to poorly di erentiated serous adenocarcinomas.
Some rare forms of ovarian cancer, such as germ cell tumors, can occur in children and young women. About one in 75 women will develop ovarian cancer at some point in their lives.
Ovarian cancer enzyme No. 7 specifically helps to slow down the growth and spread of cancer cells in the organism. Cancer cells employ various strategies to avoid being destroyed by the body's immune system.
For example, they camouflage themselves with a cover made of an endogenous material and can thus migrate to other parts of the body undetected. Our ovarian cancer enzyme number 7 recognizes these camouflaged cells and destroys them. In this way, metastases can be effectively prevented.
Another deception of the cancer cells is also undermined by our ovarian cancer enzyme No. 7: The cancer cells produce structures that are classified as harmful and attacked by the immune system.
Cancer cells that are still alive remain unmolested and have a free path to multiply. Ovarian cancer enzyme number 7 is able to split the deceptive structures. Recommended daily dose: 1 x 1 capsule
